Resilience
Announced 23 Nov 2020$750.0M · Series B · Pharmaceutical Manufacturing · United States
Resilience is a North American contract development and manufacturing organization (CDMO) focused on delivering high-quality, scalable manufacturing solutions for advanced therapies.
“RESILIENCE Launches to Change the Future of Medicine through Manufacturing Innovation Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type.”
Investors: 8VC, Arch Venture Partners (lead).